Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:58 AM UTC
| NCT Number | NCT04861077 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 17, 2026: Clinical trial NCT04861077 is currently recruiting participants. This early_phase1 study for triple negative breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04861077 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04861077 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.